Paternalism in practice: How we create obstacles for sexual, reproductive, and menopausal healthcare despite our best intentions
Author:
Open Access
- 3 April 2023
- journal article
- editorial
- Published by Cleveland Clinic Journal of Medicine in Cleveland Clinic Journal of Medicine
- Vol. 90 (4) , 227-233
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women’s Health Initiative Randomized Clinical TrialsJAMA, 2020
- A Study of TelecontraceptionNew England Journal of Medicine, 2019
- Safety and Tolerability of Evening Ethanol Consumption and Bedtime Administration of Flibanserin in Healthy Premenopausal Female SubjectsSexual Medicine, 2019
- Evaluation of Flibanserin Safety: Comparison with Other Serotonergic MedicationsSexual Medicine Reviews, 2019
- Flibanserin: From Bench to BedsideSexual Medicine Reviews, 2017
- FDA Approval of Flibanserin — Treating Hypoactive Sexual Desire DisorderNew England Journal of Medicine, 2016
- Duration of Menopausal Vasomotor Symptoms Over the Menopause TransitionJAMA Internal Medicine, 2015
- Postmenopausal Hormone Therapy and Risk of Cardiovascular Disease by Age and Years Since MenopauseJAMA, 2007
- Estrogen plus Progestin and the Risk of Coronary Heart DiseaseNew England Journal of Medicine, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002